Skip to main navigation Skip to search Skip to main content

SATB1 is a targetable modulator of JAK-STAT signaling and cytokines in human Treg and Tconv cells

  • Saskia Kolb
  • , Leonie Diekmann
  • , Elizabeth E. Lochert
  • , Linda Warmuth
  • , Julia Ritter
  • , Gunter Schmidtke
  • , Michael Weber
  • , Markus Hoffmann
  • , Markus List
  • , Daniel Kotlarz
  • , Isabelle Serr
  • , Carolin Daniel
  • , Dirk H. Busch
  • , Christian Schmidl
  • , Kathrin Schumann
  • Technical University of Munich
  • Universitat Konstanz
  • National Institutes of Health
  • Georgetown University Medical Center
  • Ludwig-Maximilians-Universität München
  • Helmholtz Zentrum München German Research Center for Environmental Health
  • German Center of Child and Adolescent Health (DZKJ)
  • Helmholtz AI and Helmholtz Munich
  • German Centre for Diabetes Research (DZD)
  • Partner Site Munich
  • Leibniz Institute for Immuntherapie (LIT)

Research output: Contribution to journalArticlepeer-review

Abstract

The chromatin organizer SATB1 is indispensable for thymic regulatory T cell (Treg cell) development and T helper cell induction. Several gene loci have been described to be SATB1-controlled, including the transcription factor GATA3 and the cytokine loci IL-4 and IL-17. However, the global effects of SATB1 on fully differentiated human CD4 conventional T cells (Tconv cells) and Treg cells, and thus the potential of SATB1 as a target for T-cell engineering, are poorly understood. Here, we describe SATB1-regulated gene signatures as largely subset-specific, with broader effects on Treg cells. Despite distinct gene-regulatory patterns, we observe overarching dysregulated cytokine and JAK-STAT signaling after SATB1 ablation. Functionally, SATB1 KO reduces suppressive capacities of human Treg cells but boosts tumor clearance via CD4 CAR T cells in a preclinical, humanized mouse model. Taken together, Treg destabilization and simultaneous increased activation of CD4 CAR T cells by SATB1 modulation may be a strategy to boost the efficiency of CAR T cell therapies.

Original languageEnglish
JournalEMBO Reports
DOIs
StateAccepted/In press - 2026

Fingerprint

Dive into the research topics of 'SATB1 is a targetable modulator of JAK-STAT signaling and cytokines in human Treg and Tconv cells'. Together they form a unique fingerprint.

Cite this